Cancer risk rises with autoimmune disorders but drops after anti-inflammatory therapy, finds study

When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, according to a new five-year study tracking people with immune-mediated inflammatory diseases (IMID). Scientists theorize that the anti-inflammatory treatment for these diseases provides potential protective effects, reversing the increased cancer risk caused by high inflammation.